The Role of Anti-MDA5 Antibodies in Rapidly Progressive InterstitialLung Disease: A Case Report and Literature Review

This case underscores the need for increased awareness of this condition among clinicians to improve early diagnosis and treatment outcomes.

Authors

Institutions

Publication Details

Journal
Reviews on Recent Clinical Trials
Published
2025-05-14
DOI
https://doi.org/10.2174/0115748871350269250507052714
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of Anti-MDA5 Antibodies in Rapidly Progressive InterstitialLung Disease: A Case Report and Literature Review

Luigi La Via, Alice Cerato, Matteo Nicoletto, V. Grosso et al.
Reviews on Recent Clinical Trials
Inflammatory Myopathies and Dermatomyositis
article

The Role of Anti-MDA5 Antibodies in Rapidly Progressive InterstitialLung Disease: A Case Report and Literature Review

Luigi La Via, Alice Cerato, Matteo Nicoletto, V. Grosso, Fulvio Pomero, Eleonora Galli, Alberto Grosso, Francisca Bulai, Irene Praticò, Cristina Olivero, F Diana
article en

Abstract

This case underscores the need for increased awareness of this condition among clinicians to improve early diagnosis and treatment outcomes.

Reviews on Recent Clinical TrialsVol. 20
Policlinico Universitario di Catania (IT), Ospedale San Pietro Fatebenefratelli (IT), University of Turin (IT)
Good health and well-being
Openalex Percentile: Top 84%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.